Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Not yet recruiting · NCT06200233 · Registry updated 2024-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor | thymic epithelial neoplasm | Not yet recruiting | Phase 2 | 2024-04-09 | NCT06200233 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Samsung Medical Center | 207 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine | Seoul | South Korea | 1 |